Clinical Trial Update: Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether N-acetylcysteine can improve myocardial salvage and reduce contrast-induced nephropathy in myocardial infarction patients has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Leipzig | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED